Eric van der Helm

Eric van der Helm

Auto-generated profile, based on publicly available information

Eric van der Helm

SNIPR Biome , Copenhagen

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2023 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
YGYilmaz Emre Gencay
Yilmaz Emre Gencay
DJDziuginta Jakociune
Dziuginta Jakociune
CRCamille Robert
Camille Robert
SSSzabolcs Semsey
Szabolcs Semsey
VMVirginia Martínez
Virginia Martínez
MSMorten Otto Alexander Sommer
Morten Otto Alexander Sommer
Antibiotic treatments have detrimental effects on the microbiome and lead to antibiotic resistance. To develop a phage therapy against a diverse range of clinically relevant Escherichia coli, we screened a library of 162 wild-type (WT) phages, identifying eight phages with broad coverage of E. coli, complementary binding to bacterial surface receptors, and the capability to stably carry inserted cargo. Selected phages were engineered with tail fibers and CRISPR–Cas machinery to specifically target E. coli. We show that engineered phages target bacteria in biofilms, reduce the emergence of phage-tolerant E. coli and out-compete their ancestral WT phages in coculture experiments. A combination of the four most complementary bacteriophages, called SNIPR001, is well tolerated in both mouse models and minipigs and reduces E. coli load in the mouse gut better than its constituent components separately. SNIPR001 is in clinical development to selectively kill E. coli, which may cause fatal infections in hematological cancer patients.

1 February 2019 in Cell Host & Microbe
Verified
Journal Article
Closed access
RURuben V. Uribe
Ruben V. Uribe
EHEric van der Helm
Eric van der Helm
MMMaria-Anna Misiakou
Maria-Anna Misiakou
SLSang-Woo Lee
Sang-Woo Lee
SKStefan Kol
Stefan Kol
MSMorten O.A. Sommer
Morten O.A. Sommer

1 February 2019 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
JLJun Li
Jun Li
ERElizabeth Rettedal
Elizabeth Rettedal
EHEric van der Helm
Eric van der Helm
MEMostafa Ellabaan
Mostafa Ellabaan
GPGianni Panagiotou
Gianni Panagiotou
MSMorten O.A. Sommer
Morten O.A. Sommer
Despite the documented antibiotic-induced disruption of the gut microbiota, the impact of antibiotic intake on strain-level dynamics, evolution of resistance genes, and factors influencing resistance dissemination potential remains poorly understood. To address this gap we analyzed public metagenomic datasets from 24 antibiotic treated subjects and controls, combined with an in-depth prospective functional study with two subjects investigating the bacterial community dynamics based on cultivation-dependent and independent methods. We observed that short-term antibiotic treatment shifted and diversified the resistome composition, increased the average copy number of antibiotic resistance genes, and altered the dominant strain genotypes in an individual-specific manner. More than 30% of the resistance genes underwent strong differentiation at the single nucleotide level during antibiotic treatment. We found that the increased potential for horizontal gene transfer, due to antibiotic administration, was ∼3-fold stronger in the differentiated resistance genes than the non-differentiated ones. This study highlights how antibiotic treatment has individualized impacts on the resistome and strain level composition, and drives the adaptive evolution of the gut microbiota.

6 January 2017 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
EHEric van der Helm
Eric van der Helm
LILejla Imamovic
Lejla Imamovic
MEMostafa M. Hashim Ellabaan
Mostafa M. Hashim Ellabaan
WSWillem van Schaik
Willem van Schaik
AKAnna Koza
Anna Koza
MSMorten O.A. Sommer
Morten O.A. Sommer
The emergence of antibiotic resistance in human pathogens has become a major threat to modern medicine. The outcome of antibiotic treatment can be affected by the composition of the gut. Accordingly, knowledge of the gut resistome composition could enable more effective and individualized treatment of bacterial infections. Yet, rapid workflows for resistome characterization are lacking. To address this challenge we developed the poreFUME workflow that deploys functional metagenomic selections and nanopore sequencing to resistome mapping. We demonstrate the approach by functionally characterizing the gut resistome of an ICU (intensive care unit) patient. The accuracy of the poreFUME pipeline is with >97% sufficient for the annotation of antibiotic resistance genes. The poreFUME pipeline provides a promising approach for efficient resistome profiling that could inform antibiotic treatment decisions in the future.

16 July 2018 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
EHEric van der Helm
Eric van der Helm
HGHans J. Genee
Hans J. Genee
MSMorten O. A. Sommer
Morten O. A. Sommer

24 August 2024 in Synthetic Biology
Verified
Journal Article
Open access
PDF file
CKCamilla S Kristensen
Camilla S Kristensen
APAnders Ø Petersen
Anders Ø Petersen
MKMogens Kilstrup
Mogens Kilstrup
EHEric van der Helm
Eric van der Helm
ATAdam Takos
Adam Takos
Bacteriophages are promising alternatives to traditional antimicrobial treatment of bacterial infections. To further increase the potential of phages, efficient engineering methods are needed. This study investigates an approach to phage engineering based on phage rebooting and compares selected methods of assembly and rebooting of phage genomes. Golden Gate assembly of phage genomes and subsequent rebooting by cell-free transcription-translation reactions yielded the most efficient phage engineering and allowed production of a proof-of-concept T7 phage library of 1.8.107 phages. We obtained 7.5.106 different phages, demonstrating generation of large and diverse libraries suitable for high-throughput screening of mutant phenotypes. Implementing versatile and high-throughput phage engineering methods allows vastly accelerated and improved phage engineering, bringing us closer to applying effective phages to treat infections in the clinic.